English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

An apparently healthy 2½-year-old male Grant’s Zebra weighing approximately 200kg located at Nandankanan Zoological Park, Odisha, India, procured from Zoological Centre, Tel Aviv- Ramat Gan, Israel during September 2015 was noticed in a sitting position making frequent attempts to get up.  The zebra was immobilised the same day with a combination of 1.96mg etorphine hydrochloride, 8.0mg of acepromazine and 40.0mg of xylazine hydrochloride to facilitate diagnosis and treatment.  Clinical examinations did not reveal any signs suggestive of disease or disorder of the musculoskeletal system.  Microscopic examination of blood smears stained in Giemsa’s stain revealed the presence of intra-erythrocytic inclusions, either single or pairs, suggestive of haemoprotozoans, i.e., B. caballi and/or T. equi.  The zebra was administered with two divided doses of imidocarb injection @4.0mg/kg b.wt. deep intramuscularly in the neck region with supportive therapy.  Progressive improvement in posture, gait, and appetite were noticed following 24h of medication.  Three more doses of imidocarb were administered at 72h intervals, each time after immobilisation.

Piroplasmosis in a captive Grant’s Zebra Equus quagga boehmi (Mammalia: Perissodactyla: Equidae) - a case study